Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Halpern

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Reviews in Endocrine & Metabolic Disorders|July 2, 2025
Emerging evidence and potential avenues to achieve durable outcomes in patients with obesity: the confluence of nutrition, and Microbiome on body compositionDra M Isabel T D Correia, Nitin Kapoor, Emma Chávez-Manzanera, et al.
Nature Medicine|February 27, 2024
Author Correction: Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trialThomas A Wadden, Ariana M Chao, Sriram Machineni, et al.
Nature Medicine|October 15, 2023
Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trialThomas A Wadden, Ariana M Chao, Sriram Machineni, et al.
Lancet Regional Health. Americas|January 16, 2026
Waist-to-height ratio and coronary artery calcium incidence: the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)Thiago Bosco Mendes, Giuliano Generoso, Ronaldo C Fabiano, et al.
Clinical Obesity|January 14, 2026
Classification of Obesity Based on Weight History: Perceptions of People With ObesityBruno Halpern, Simone van de Sande-Lee, Maria Edna de Melo, et al.
Archives of Endocrinology and Metabolism|March 25, 2025
Care of patients with obesity in the Emergency Department: a joint position statement from the Brazilian Association of Emergency Medicine (ABRAMEDE) and the Brazilian Association for the Study of Obesity and Metabolic Syndrome (ABESO)Rafael Lima McGregor von Hellmann, Simone van de Sande-Lee, Maria Edna Melo, et al.
The New England Journal of Medicine|September 17, 2025
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity TreatmentSean Wharton, Louis J Aronne, Adam Stefanski, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|November 24, 2020
Obesity and COVID-19 in Latin America: A tragedy of two pandemics-Official document of the Latin American Federation of Obesity SocietiesBruno Halpern, Maria Laura da Costa Louzada, Pablo Aschner, et al.
Diabetes|February 16, 2019
Melatonin Increases Brown Adipose Tissue Volume and Activity in Patients With Melatonin Deficiency: A Proof-of-Concept StudyBruno Halpern, Marcio C Mancini, Clarissa Bueno, et al.
The New England Journal of Medicine|November 13, 2024
Tirzepatide for Obesity Treatment and Diabetes PreventionAnia M Jastreboff, Carel W le Roux, Adam Stefanski, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Reviews in Endocrine & Metabolic Disorders|July 2, 2025
Emerging evidence and potential avenues to achieve durable outcomes in patients with obesity: the confluence of nutrition, and Microbiome on body compositionDra M Isabel T D Correia, Nitin Kapoor, Emma Chávez-Manzanera, et al.
Nature Medicine|February 27, 2024
Author Correction: Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trialThomas A Wadden, Ariana M Chao, Sriram Machineni, et al.
Nature Medicine|October 15, 2023
Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trialThomas A Wadden, Ariana M Chao, Sriram Machineni, et al.
Lancet Regional Health. Americas|January 16, 2026
Waist-to-height ratio and coronary artery calcium incidence: the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)Thiago Bosco Mendes, Giuliano Generoso, Ronaldo C Fabiano, et al.
Clinical Obesity|January 14, 2026
Classification of Obesity Based on Weight History: Perceptions of People With ObesityBruno Halpern, Simone van de Sande-Lee, Maria Edna de Melo, et al.
Archives of Endocrinology and Metabolism|March 25, 2025
Care of patients with obesity in the Emergency Department: a joint position statement from the Brazilian Association of Emergency Medicine (ABRAMEDE) and the Brazilian Association for the Study of Obesity and Metabolic Syndrome (ABESO)Rafael Lima McGregor von Hellmann, Simone van de Sande-Lee, Maria Edna Melo, et al.
The New England Journal of Medicine|September 17, 2025
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity TreatmentSean Wharton, Louis J Aronne, Adam Stefanski, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|November 24, 2020
Obesity and COVID-19 in Latin America: A tragedy of two pandemics-Official document of the Latin American Federation of Obesity SocietiesBruno Halpern, Maria Laura da Costa Louzada, Pablo Aschner, et al.
Diabetes|February 16, 2019
Melatonin Increases Brown Adipose Tissue Volume and Activity in Patients With Melatonin Deficiency: A Proof-of-Concept StudyBruno Halpern, Marcio C Mancini, Clarissa Bueno, et al.
The New England Journal of Medicine|November 13, 2024
Tirzepatide for Obesity Treatment and Diabetes PreventionAnia M Jastreboff, Carel W le Roux, Adam Stefanski, et al.
Pageof 7